Adult patients with congenital heart disease and pulmonary arterial hypertension: First open prospective multicenter study of bosentan therapy
- 31 October 2005
- journal article
- clinical trial
- Published by Elsevier in American Heart Journal
- Vol. 150 (4) , 716.e7-716.e12
- https://doi.org/10.1016/j.ahj.2005.07.005
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Guidelines on diagnosis and treatment of pulmonary arterial hypertension. The Task Force on Diagnosis and Treatment of Pulmonary Arterial Hypertension of the European Society of Cardiology.Published by Oxford University Press (OUP) ,2004
- Pulmonary Arterial HypertensionNew England Journal of Medicine, 2004
- Endothelin receptor antagonists in pulmonary arterial hypertensionJournal of the American College of Cardiology, 2004
- The endothelin system in pulmonary arterial hypertensionCardiovascular Research, 2004
- BosentanHeart Disease, 2003
- Effects of bosentan on cellular processes involved in pulmonary arterial hypertension: do they explain the long‐term benefit?Annals of Medicine, 2003
- Eisenmenger's syndrome: Current managementProgress in Cardiovascular Diseases, 2002
- Effects of the dual endothelin-receptor antagonist bosentan in patients with pulmonary hypertension: a randomised placebocontrolled studyThe Lancet, 2001
- The Eisenmenger Syndrome in AdultsAnnals of Internal Medicine, 1998
- The Eisenmenger Syndrome: IIBMJ, 1958